Overview Fundamentals API Earnings EOD API Sample Code Pricing

BioXcel Therapeutics Inc (BTAI NASDAQ) stock market data APIs

$1.18 -0.01(-0.8%) as of July 23, 2024
Price chart is built with Anychart

BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI, a sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the acute treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally innate immunity activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors; BXCL503, a drug candidate to target apathy in dementia; and BXCL504, a drug candidate to target aggression in dementia. BioXcel Therapeutics, Inc. was incorporated in 2017 and is headquartered in New Haven, Connecticut.

BioXcel Therapeutics Inc Financial Data Overview

44 662 K
37 531 K
1 756 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BTAI',
Type: 'Common Stock',
Name: 'BioXcel Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00K20GVD2',
CIK: '1720893',
EmployerIdNumber: '82-1386754',
FiscalYearEnd: 'December',
IPODate: '2018-03-08',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

BioXcel Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 756 K
  • EBITDA -140 268 000
  • Earnings Per Share -5.18
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get BioXcel Therapeutics Inc Earnings via APIs

  • Latest Release 2024-07-16
  • EPS/Forecast -0.71

Get BioXcel Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?